Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Miami Lakes. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Miami Lakes at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
This is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of 3 different dose regiments of KYN-5356 and placebo for 28 days. Participants will be randomized to one of 4 treatment groups: placebo, KYN-5356 low dose, KYN-5356 medium dose, KYN-5356 high dose. Participants will be admitted to the clinic on Day -3 and will remain in residence at the clinic for 32 days, from baseline through the treat
Sponsor: Kynexis B.V.
Check if you qualify for this schizophrenia clinical trial in Miami Lakes, FL
If you're searching for schizophrenia treatment options in Miami Lakes, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami Lakes research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.